Spot on.
Why do you do a webinar simply to read what it is in announcement.
Take your time (few weeks?), Do the analysis with expert including Prof. Frazer and explain the market/SH what it mean via webinar, let the Q/A session run in the webinar to address any question the SHs have.. What the way forward is. etc etc.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-158
-
- There are more pages in this discussion • 193 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M | |||
| Open | High | Low | Value | Volume |
| $15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 297 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.25 | 1300 | 2 |
View Market Depth
| Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |